Correlation of high PRDX4 expression with poor prognosis in patients with ESCA: Bioinformatics and in vitro validation
Xing Liu, Lanlan Pan, Huichao Song, Wenyan Pan · 2026
Read Correlation of high PRDX4 expression with poor prognosis in patients with ESCA: Bioinformatics and in vitro validation by Xing Liu, Lanlan Pan, Huichao Song, Wenyan Pan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13635726.txt.
Description
Xing Liu, Lanlan Pan, Huichao Song, and Wenyan Pan studied a protective protein that runs high in cancer of the food pipe, in this 2026 paper. The protein, called PRDX4, normally shields cells from chemical damage. The team asked whether tumors of the esophagus make too much of it, and whether patients with higher levels fare worse.
Searching large cancer databases, they found the protein raised in tumor tissue and tied to shorter survival. They then stained sixty tumor samples and matched healthy tissue in the lab. Every tumor sample stained strongly, while few healthy ones did. Higher levels also tracked with more advanced stage and with the mix of immune cells around the tumor. The authors suggest the protein could serve as a warning marker and, in time, perhaps a target for treatment.
Catalog record
| CREATOR | Xing Liu, Lanlan Pan, Huichao Song, Wenyan Pan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |